HealthyWay Affiliate to Sell 51% Stake in Fujian Jianchen Pharmaceutical

Deep News2025-12-26

HEALTHYWAY INC (02587) announced that on December 24, 2025, its wholly-owned subsidiary, Zhejiang Healthy Way Technology Group Co., Ltd., intends to sell a 51% equity stake in Fujian Jianchen Pharmaceutical Co., Ltd. to Ms. Xiao Jing for a total consideration of RMB 1.6779 million. The primary business activities of the company being sold involve drug wholesaling, operating Class III medical devices, and selling Class I and Class II medical devices.

The company being divested experienced a temporary surge in revenue due to stockpiling Oseltamivir during the influenza outbreak at the end of 2023. However, as the pandemic subsided, the limitations of the company operating as a single-product inventory drug wholesaler became apparent. Starting from August 2024, drugs procured under purchase and sale agreements with other pharmaceutical companies failed to deliver the expected performance, leading to a significant decline in both revenue and net profit. Given the relatively high fixed costs associated with drug procurement, warehousing, transportation, and employee compensation, coupled with the failure to meet operational performance targets, the Group decided to divest its stake in the company to reduce costs and improve efficiency. The Company plans to use the proceeds from the sale for the development of the Group's enterprise services and digital marketing services.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1106101454?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-26 09:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106101454","market":"sh","top_or_hot":-1,"title":"HealthyWay Affiliate to Sell 51% Stake in Fujian Jianchen Pharmaceutical","media":"Deep News","content":"<p>HEALTHYWAY INC (02587) announced that on December 24, 2025, its wholly-owned subsidiary, Zhejiang Healthy Way Technology Group Co., Ltd., intends to sell a 51% equity stake in Fujian Jianchen Pharmaceutical Co., Ltd. to Ms. Xiao Jing for a total consideration of RMB 1.6779 million. The primary business activities of the company being sold involve drug wholesaling, operating Class III medical devices, and selling Class I and Class II medical devices.</p>\n<p>The company being divested experienced a temporary surge in revenue due to stockpiling Oseltamivir during the influenza outbreak at the end of 2023. However, as the pandemic subsided, the limitations of the company operating as a single-product inventory drug wholesaler became apparent. Starting from August 2024, drugs procured under purchase and sale agreements with other pharmaceutical companies failed to deliver the expected performance, leading to a significant decline in both revenue and net profit. Given the relatively high fixed costs associated with drug procurement, warehousing, transportation, and employee compensation, coupled with the failure to meet operational performance targets, the Group decided to divest its stake in the company to reduce costs and improve efficiency. The Company plans to use the proceeds from the sale for the development of the Group's enterprise services and digital marketing services.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HealthyWay Affiliate to Sell 51% Stake in Fujian Jianchen Pharmaceutical</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthyWay Affiliate to Sell 51% Stake in Fujian Jianchen Pharmaceutical\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-12-26 09:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HEALTHYWAY INC (02587) announced that on December 24, 2025, its wholly-owned subsidiary, Zhejiang Healthy Way Technology Group Co., Ltd., intends to sell a 51% equity stake in Fujian Jianchen Pharmaceutical Co., Ltd. to Ms. Xiao Jing for a total consideration of RMB 1.6779 million. The primary business activities of the company being sold involve drug wholesaling, operating Class III medical devices, and selling Class I and Class II medical devices.</p>\n<p>The company being divested experienced a temporary surge in revenue due to stockpiling Oseltamivir during the influenza outbreak at the end of 2023. However, as the pandemic subsided, the limitations of the company operating as a single-product inventory drug wholesaler became apparent. Starting from August 2024, drugs procured under purchase and sale agreements with other pharmaceutical companies failed to deliver the expected performance, leading to a significant decline in both revenue and net profit. Given the relatively high fixed costs associated with drug procurement, warehousing, transportation, and employee compensation, coupled with the failure to meet operational performance targets, the Group decided to divest its stake in the company to reduce costs and improve efficiency. The Company plans to use the proceeds from the sale for the development of the Group's enterprise services and digital marketing services.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09939","symbol_name":"开拓药业-B","start_time":0,"source_url":"","article_id":"1106101454","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106101454","pubTimestamp":1766713394,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"HEALTHYWAY INC (02587) announced that on December 24, 2025, its wholly-owned subsidiary, Zhejiang Healthy Way Technology Group Co., Ltd., intends to sell a 51% equity stake in Fujian Jianchen...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","09939":"开拓药业-B","BK1219":"保健护理服务","BK1515":"抗疫概念","BK1161":"生物科技","BK1574":"生物医药B类股","02587":"健康之路"},"translate_title":"HealthyWay关联公司将出售福建建辰药业51%股权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"02587":1,"09939":1},"content_text":"HEALTHYWAY INC (02587) announced that on December 24, 2025, its wholly-owned subsidiary, Zhejiang Healthy Way Technology Group Co., Ltd., intends to sell a 51% equity stake in Fujian Jianchen Pharmaceutical Co., Ltd. to Ms. Xiao Jing for a total consideration of RMB 1.6779 million. The primary business activities of the company being sold involve drug wholesaling, operating Class III medical devices, and selling Class I and Class II medical devices.\nThe company being divested experienced a temporary surge in revenue due to stockpiling Oseltamivir during the influenza outbreak at the end of 2023. However, as the pandemic subsided, the limitations of the company operating as a single-product inventory drug wholesaler became apparent. Starting from August 2024, drugs procured under purchase and sale agreements with other pharmaceutical companies failed to deliver the expected performance, leading to a significant decline in both revenue and net profit. Given the relatively high fixed costs associated with drug procurement, warehousing, transportation, and employee compensation, coupled with the failure to meet operational performance targets, the Group decided to divest its stake in the company to reduce costs and improve efficiency. The Company plans to use the proceeds from the sale for the development of the Group's enterprise services and digital marketing services.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1106101454","isCrawlerRequest":true}